PNPLA1 Protein (AA 1-599) (Strep Tag)

N° du produit ABIN3122279

Détail du produit

Antigène: PNPLA1 (Patatin-Like phospholipase Domain Containing 1 (PNPLA1))

Type de proteíne: Recombinant

Attributs du protein: AA 1-599

Origine: Souris

Source: Tobacco (Nicotiana tabacum)

Purification/Conjugué: Cette PNPLA1 protéine est marqué à la Strep Tag.

Application: ELISA, SDS-PAGE (SDS), Western Blotting (WB)

Séquence: MDEQVFKGDP DTPHSISFSG SGFLSYYQAG AVDALRDLAP RMLDTAHRFA GTSAGAVIAA LVVCGIEMEK YLRVLNMGLA EVKKFFLGPL SPSCKMVQMM RQFLYDVLPE DSYKFATGKL HVSLTRVTDG ENVVVSEYRS KEELIEALYC SCFVPVYCGF IPPTYRGERY IDGGFTSMQP CSFWTDSITI STFSSQQDIC PRDCPTIFHD FRMFNFSFQF SLENITRMTH ALFPPDLVIL QEYYYRGYND AVSYLRRLNA AYLDSPSKRV IFPRVEVYCQ IEVALGHEPP PPSLQNLPAL RRSPADSSQT HAQGSPKKDR KDSHSSAAPS VQTPESGCKE SVESPVSLRV SISKQPSVSP LSPAQPVPVM RPTGPRDSCP INVQTPNPER GVKGALDSAT ERGMKDALAS ATDEQSTTTL PPVLLPAADS RGSKTGSSVP IGSPESPRLL LRSSQGATAS RATLGLPPLS PSTPPAGPPV EDLGPERPTA TGSPALSQLT GSAAPGTGKK APHKPLLVEG PGEDSNTAKT MFKRKQKTNA TRECFHRNAQ SKKPASKLKS APCPLNFPVL PKRVWVTYKP HPSRIQDYSY PEGVSGQNS
Sequence without tag. The proposed Strep-Tag is based on experience s with the expression system, a different complexity of the protein could make another tag necessary. In case you have a special request, please contact us.

Attributs du produit: Key Benefits:

• Made in Germany - from design to production - by highly experienced protein experts.
• Protein expressed with ALiCE® and purified by multi-step, protein-specific process to ensure correct folding and modification.
• These proteins are normally active (enzymatically functional) as our customers have reported (not tested by us and not guaranteed).
• State-of-the-art algorithm used for plasmid design (Gene synthesis).

This protein is a made-to-order protein and will be made for the first time for your order. Our experts in the lab will ensure that you receive a correctly folded protein.

The big advantage of ordering our made-to-order proteins in comparison to ordering custom made proteins from other companies is that there is no financial obligation in case the protein cannot be expressed or purified.

Expression System:

• ALiCE®, our Almost Living Cell-Free Expression System is based on a lysate obtained from Nicotiana tabacum c.v.. This contains all the protein expression machinery needed to produce even the most difficult-to-express proteins, including those that require post-translational modifications.
• During lysate production, the cell wall and other cellular components that are not required for protein production are removed, leaving only the protein production machinery and the mitochondria to drive the reaction. During our lysate completion steps, the additional components needed for protein production (amino acids, cofactors, etc.) are added to produce something that functions like a cell, but without the constraints of a living system - all that's needed is the DNA that codes for the desired protein!

Concentration:

• The concentration of our recombinant proteins is measured using the absorbance at 280nm.
• The protein's absorbance will be measured in several dilutions and is measured against its specific reference buffer.
• We use the Expasy's protparam tool to determine the absorption coefficient of each protein.

Purification: Two step purification of proteins expressed in Almost Living Cell-Free Expression System (ALiCE®):

1. In a first purification step, the protein is purified from the cleared cell lysate using StrepTag capture material. Eluate fractions are analyzed by SDS-PAGE.
2. Protein containing fractions of the best purification are subjected to second purification step through size exclusion chromatography. Eluate fractions are analyzed by SDS-PAGE and Western blot.

Pureté: ≥ 80 % as determined by SDS PAGE, Size Exclusion Chromatography and Western Blot.

niveau d'endotoxine: Low Endotoxin less than 1 EU/mg (< 0.1 ng/mg)

Classe de qualité: Crystallography grade

Information d'application

Indications d'application: In addition to the applications listed above we expect the protein to work for functional studies as well. As the protein has not been tested for functional studies yet we cannot offer a guarantee though.

Commentaires:

ALiCE®, our Almost Living Cell-Free Expression System is based on a lysate obtained from Nicotiana tabacum c.v.. This contains all the protein expression machinery needed to produce even the most difficult-to-express proteins, including those that require post-translational modifications.
During lysate production, the cell wall and other cellular components that are not required for protein production are removed, leaving only the protein production machinery and the mitochondria to drive the reaction. During our lysate completion steps, the additional components needed for protein production (amino acids, cofactors, etc.) are added to produce something that functions like a cell, but without the constraints of a living system - all that's needed is the DNA that codes for the desired protein!

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: The buffer composition is at the discretion of the manufacturer. If you have a special request, please contact us.

Conseil sur la manipulation: Avoid repeated freeze-thaw cycles.

Stock: -80 °C

Stockage commentaire: Store at -80°C.

Date de péremption: Unlimited (if stored properly)

Détail du antigène

Antigène: PNPLA1 (Patatin-Like phospholipase Domain Containing 1 (PNPLA1))

Autre désignation: Pnpla1 (PNPLA1 Produits)

Synonymes: ARCI10 Protein, dJ50J22.1 Protein, patatin like phospholipase domain containing 1 Protein, patatin-like phospholipase domain containing 1 Protein, PNPLA1 Protein, Pnpla1 Protein

Sujet: Omega-hydroxyceramide transacylase (EC 2.3.1.296) (Patatin-like phospholipase domain-containing protein 1),FUNCTION: Omega-hydroxyceramide transacylase involved in the synthesis of omega-O-acylceramides (esterified omega-hydroxyacyl-sphingosine, EOS), which are extremely hydrophobic lipids involved in skin barrier formation (PubMed:27751867, PubMed:28248300). Catalyzes the last step of the synthesis of omega-O-acylceramides by transferring linoleic acid from triglycerides to an omega-hydroxyceramide (PubMed:27751867, PubMed:28248300). Omega-O-acylceramides, are required for the biogenesis of lipid lamellae in the stratum corneum and the formation of the cornified lipid envelope which are essential for the epidermis barrier function (PubMed:27751867, PubMed:28248300). These lipids also play a role in keratinocyte differentiation (PubMed:28248300). May also act on omega-hydroxylated ultra-long chain fatty acids (omega-OH ULCFA) and acylglucosylceramides (GlcEOS) (PubMed:28248300). {ECO:0000269|PubMed:27751867, ECO:0000269|PubMed:28248300}.

Poids moléculaire: 65.2 kDa

UniProt: Q3V1D5